JP Patent

JP7311268B2 — 光線力学療法のための局所用組成物、閉塞性ドレッシング材、それを用いたキット、光線力学療法材料、および光線力学療法のための方法

Assigned to Dusa Pharmaceuticals Inc · Expires 2023-07-19 · 3y expired

What this patent protects

Patent listed against aminolevulinic-acid-hydrochloride.

Drugs covered by this patent

aminolevulinic-acid-hydrochloride (AMINOLEVULINIC ACID HYDROCHLORIDE)

Patent Metadata

Patent number: JP7311268B2
Jurisdiction: JP
Classification: —
Expires: 2023-07-19
Drug substance claim: No
Drug product claim: No
Assignee: Dusa Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.